|
1
|
Gloss BS and Samimi G: Epigenetic
biomarkers in epithelial ovarian cancer. Cancer Lett. 342:257–263.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Krzystyniak J, Ceppi L, Dizon DS and
Birrer MJ: Epithelial ovarian cancer: The molecular genetics of
epithelial ovarian cancer. Ann Oncol. 27 (Suppl 1):i4–i10. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Epidemiology Working Group Steering
Committee, Ovarian Cancer Association Consortium Members of the EWG
SC, ; Doherty JA, Jensen A, Kelemen LE, Pearce CL, Poole E,
Schildkraut JM, Terry KL, Tworoger SS, et al: Current gaps in
ovarian cancer epidemiology: The need for new population-based
research. J Natl Cancer Inst. 109:djx1442017.
|
|
4
|
Lheureux S, Gourley C, Vergote I and Oza
AM: Epithelial ovarian cancer. Lancet. 393:1240–1253. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Khairallah AS, Genestie C, Auguste A and
Leary A: Impact of neoadjuvant chemotherapy on the immune
microenvironment in advanced epithelial ovarian cancer: Prognostic
and therapeutic implications. Int J Cancer. 143:8–15. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang Y, Zhang Y, Jia L, Liu C and Xu F:
Circular RNA ABCB10 promotes tumor progression and correlates with
pejorative prognosis in clear cell renal cell carcinoma. Int J Biol
Markers. 34:176–183. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang HF, Zhang XZ, Liu BG, Jia GT and Li
WL: Circular RNA circ-ABCB10 promotes breast cancer proliferation
and progression through sponging miR-1271. Am J Cancer Res.
7:1566–1576. 2017.PubMed/NCBI
|
|
8
|
Tian X, Zhang L, Jiao Y, Chen J, Shan Y
and Yang W: CircABCB10 promotes nonsmall cell lung cancer cell
proliferation and migration by regulating the miR-1252/FOXR2 axis.
J Cell Biochem. 120:3765–3772. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Y, Ye X, Xia X and Lin X: Circular
RNA ABCB10 correlates with advanced clinicopathological features
and unfavorable survival, and promotes cell proliferation while
reduces cell apoptosis in epithelial ovarian cancer. Cancer
Biomark. 26:151–161. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li J, Xu J, Yan X, Jin K, Li W and Zhang
R: Suppression of Capn4 by microRNA-1271 impedes the proliferation
and invasion of colorectal cancer cells. Biomed Pharmacother.
99:162–168. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang X, Sun J, Xia D, Can X, Liu L, Zhang
J, Xu H, Du N, Liu W, Shen F, et al: Capn4 enhances osteopontin
expression through activation of the Wnt/β-catenin pathway to
promote epithelial ovarian carcinoma metastasis. Cell Physiol
Biochem. 42:185–197. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dochez V, Caillon H, Vaucel E, Dimet J,
Winer N and Ducarme G: Biomarkers and algorithms for diagnosis of
ovarian cancer: CA125, HE4, RMI and ROMA, a review. J Ovarian Res.
12:282019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao ZJ and Shen J: Circular RNA
participates in the carcinogenesis and the malignant behavior of
cancer. RNA Biol. 14:514–521. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen B and Huang S: Circular RNA: An
emerging non-coding RNA as a regulator and biomarker in cancer.
Cancer Lett. 418:41–50. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu X, Ma L, Rao Q, Mao Y, Xin Y, Xu H, Li
C and Wang X: miR-1271 inhibits ovarian cancer growth by targeting
cyclin G1. Med Sci Monit. 21:3152–3158. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiao Y, Zhu G, Yu J, Mao Y, Xin Y, Xu H,
Li C and Wang X: miR-1271 inhibits growth, invasion and
epithelial-mesenchymal transition by targeting ZEB1 in ovarian
cancer cells. Onco Targets Ther. 12:6973–6980. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chi Y, Jin Q, Liu X, Xu L, He X, Shen Y,
Zhou Q, Zhang J and Jin M: miR-203 inhibits cell proliferation,
invasion, and migration of non-small-cell lung cancer by
downregulating RGS17. Cancer Sci. 108:2366–2372. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Du HY and Liu B: miR-1271 as a tumor
suppressor in breast cancer proliferation and progression via
targeting SPIN1. Eur Rev Med Pharmacol Sci. 22:2697–2706.
2018.PubMed/NCBI
|
|
20
|
Bodnar L, Stanczak A, Cierniak S, Smoter
M, Cichowicz M, Kozlowski W, Szczylik C, Wieczorek M and
Lamparska-Przybysz M: Wnt/β-catenin pathway as a potential
prognostic and predictive marker in patients with advanced ovarian
cancer. J Ovarian Res. 7:162014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arend RC, Londoño-Joshi AI, Straughn JM Jr
and Buchsbaum DJ: The Wnt/β-catenin pathway in ovarian cancer: A
review. Gynecol Oncol. 131:772–779. 2013. View Article : Google Scholar : PubMed/NCBI
|
